What kind of knee damage do you actually have?

The choice between “cartilage repair”, “realignment” and “bracing” is driven less by the name of a procedure and more by what the knee shows on X‑ray/MRI: where the damage sits (medial/inner, lateral/outer, patellofemoral), whether it is a single well‑defined defect or a broader pattern of wear, and whether the leg is bow‑legged (varus) or knock‑kneed (valgus). Knee cartilage algorithms repeatedly separate focal defects from diffuse arthritis because they behave differently and respond to different treatments. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

A practical way to picture it is “a pothole versus a worn road”. A focal cartilage defect is like a pothole: one patch of full‑thickness damage in an otherwise reasonable joint surface, often after a specific injury. Diffuse osteoarthritis is more like a worn road: wider cartilage thinning and roughening, often with bony change and loss of joint space on X‑ray, and it tends to involve a whole compartment rather than a single spot. Restorative techniques (such as grafts or cell/scaffold repairs) are mainly designed for symptomatic focal lesions in a non‑arthritic or minimally arthritic knee, not for a knee that is broadly worn out. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

Surgeons often describe severity using cartilage “grades” such as Outerbridge/ICRS. Without getting technical, grade III–IV generally means deep damage to full‑thickness loss, and these higher‑grade focal defects are the usual target for restorative cartilage procedures; widespread thinning across multiple surfaces behaves more like arthritis even if one area looks worse than the rest. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

Alignment then becomes the tie‑breaker. In varus (bow‑legged) knees, the inner (medial) compartment is overloaded; in valgus, the outer (lateral) compartment takes more load. In established unicompartmental overload—classically varus with medial wear—load‑shifting strategies (an unloader brace using a three‑point leverage system, or an osteotomy to change the mechanical axis) are often central, because a pristine cartilage “patch” is hard to protect if the knee keeps loading the same worn side. [msk_kb:5adfff34-7528-4c80-93a0-47d18191673d, trafilatura:https%3A%2F%2Fwww.ossur.com%2Fen-gb%2Fbracing-and-supports%2Funloader%2Funloader-braces]

• Isolated full‑thickness defect + otherwise preserved joint surfaces + no major malalignment: cartilage restoration options are commonly considered. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]
• Medial joint‑space narrowing + varus alignment: unloading/realignment (brace or osteotomy) is often part of the plan. [msk_kb:5adfff34-7528-4c80-93a0-47d18191673d, trafilatura:https%3A%2F%2Fwww.ossur.com%2Fen-gb%2Fbracing-and-supports%2Funloader%2Funloader-braces]
• Multi‑compartment, advanced wear: joint replacement pathways (partial or total) tend to be more realistic than cartilage repair alone. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

Which single‑stage cartilage repair might suit your knee?

Three ‘single‑stage’ options tend to sit in clear buckets: an injectable scaffold (ChondroFiller™ / “Liquid Cartilage™”), marrow stimulation plus a membrane (AMIC), or a structural “plug” graft (OATS/mosaicplasty). “Single‑stage” simply means the defect is treated in one sitting, without a separate cartilage‑harvesting operation and lab cell expansion (as happens with two‑stage ACI/MACI). [trafilatura:https%3A%2F%2Fwww.maci.com%2Fpatients%2Fbenefits-of-maci%2Fabout-maci%2F, trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

A few practical “deal‑breakers” usually sort knees into these buckets:

• Defect size: smaller focal defects (often quoted around 2–4 cm²) are more commonly considered for OATS/mosaicplasty or marrow‑stimulation approaches, while larger lesions tend to push discussion towards cell‑based techniques. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F, msk_kb:ae70b3f2-44ee-4a0b-91cb-abccc715523d]
• Bone involvement: if the problem includes the underlying bone (an osteochondral defect), a bone‑and‑cartilage graft such as OATS often fits the “shape of the problem” better than a surface‑only patch. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]
• Donor‑site tolerance: OATS uses the knee’s own donor cartilage; that trade‑off can matter in a 28‑year‑old runner as much as the defect itself. [trafilatura:https%3A%2F%2Fwww.orthospecialist.co.uk%2Foats-mr-yegappan-kalairajah.html]

ChondroFiller™ / “Liquid Cartilage™” (injectable collagen scaffold)

ChondroFiller is a cell‑free, type I collagen hydrogel scaffold designed to be placed into a debrided focal defect, where it gels within about 3–5 minutes to form a stable matrix. Some services describe ultrasound‑guided injection for suitable focal knee defects, while manufacturer and surgical descriptions often discuss arthroscopic placement; either way, the intent is the same: a scaffold that may support the knee’s own cells migrating into the defect over time. [trafilatura:https%3A%2F%2Flondoncartilage.com%2Fchondrofiller, trafilatura:https%3A%2F%2Fmeidrix.de%2Fen%2Fchondrofiller%2F]

Early knee evidence remains limited. A 2024 series of 17 patients with traumatic or degenerative knee chondral lesions reported use of ChondroFiller Liquid as a collagen scaffold with improvement in knee scores over 12 months, but this is still short follow‑up and not the same as long‑term durability. It is also repeatedly emphasised in clinical commentary that ChondroFiller is not a simple office injection to “regrow” cartilage across a whole arthritic knee; it is aimed at localised grade III–IV defects in carefully selected knees. [trafilatura:https%3A%2F%2Fwww.journal-imab-bg.org%2Fissues-2024%2Fissue4%2Fvol30issue4p5936-5941.html, trafilatura:https%3A%2F%2Fwww.carolinajointarthritis.com%2Fpost%2Fthe-facts-about-chondrofiller-dispelling-the-online-hype]

AMIC (matrix‑augmented microfracture)

AMIC is a single‑stage, keyhole cartilage repair approach that combines microfracture (to release marrow cells from bone) with a collagen I/III membrane over the defect to help stabilise the clot. Systematic summaries describe tentative short‑ to medium‑term benefits over microfracture alone in focal lesions. This “membrane plus marrow” logic reflects a wider point from cartilage restoration reviews: microfracture can relieve symptoms but produces fibrocartilage repair tissue, and durability has been a concern in some series. [wikipedia:en:29760859, trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

OATS / mosaicplasty (osteochondral autograft “plug” graft)

OATS transfers one or more cylindrical plugs of the patient’s own hyaline cartilage and underlying bone from a less weight‑bearing area into the defect, making it a one‑operation, structural solution. It is commonly framed for younger patients (often <50 years) with small focal traumatic defects, and mosaicplasty extends the concept by using multiple smaller plugs when the defect is larger. A 2025/2026 systematic review and meta‑analysis (19 studies, 736 patients; mean defect size around 3.3 cm²) reported favourable outcomes for OATS, with larger average improvements than minced cartilage repair and similar MRI repair scores—while acknowledging that donor‑site soreness is a real trade‑off. [trafilatura:https%3A%2F%2Fwww.orthospecialist.co.uk%2Foats-mr-yegappan-kalairajah.html, ai4scholar:5638c3e03734da5251541d55cbaea77a33907e31]

A memorable way to picture the choice is: scaffold (ChondroFiller) for a focal “pothole” where a matrix can be placed; membrane‑stabilised marrow repair (AMIC) when a microfracture‑type approach is being used but with added support; and a real plug (OATS) when replacing both cartilage and a small amount of underlying bone is part of the goal. In practice, a 35‑year‑old footballer with a ~2 cm² post‑traumatic femoral condyle defect often lands in the OATS/AMIC part of the discussion, while a 45‑year‑old with a slightly larger focal lesion and early wear may be offered a scaffold‑based or matrix‑augmented approach if the knee environment is still preservable—recognising that long‑term, head‑to‑head comparisons between these single‑stage options are still limited. [msk_kb:ae70b3f2-44ee-4a0b-91cb-abccc715523d, trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

When do MACI and other two‑stage cell therapies make sense?

Bigger or more complex focal cartilage defects tend to move the discussion away from ‘one‑and‑done’ options and towards cell‑based repair, where the goal is to resurface a larger area with living cartilage cells. The explanation here is kept in plain clinical terms (with references kept in the background, rather than showing raw link codes in the text).

1) What MACI and ACI actually involve (two stages)

MACI (matrix‑induced autologous chondrocyte implantation) is typically a two‑stage process: an initial knee arthroscopy to harvest a small sample of cartilage cells (chondrocytes), followed by laboratory expansion of those cells on a collagen membrane, and then a second procedure to shape and secure the cell‑seeded membrane into the prepared defect. In older first‑generation ACI, the cells were implanted under a periosteal flap, which is more technically demanding than placing a membrane.

2) Where these procedures usually fit (size, number of lesions, knee “environment”)

Modern knee cartilage algorithms usually reserve MACI/ACI for larger focal defects (commonly discussed in the 2–10 cm² range) or multiple symptomatic lesions, provided the knee is still a “preservable” environment (for example, a stable joint without end‑stage, multi‑compartment osteoarthritis). One practical anchor from comparative evidence is the SUMMIT trial, where MACI showed better patient‑reported outcomes than microfracture at 2 and 5 years in defects ≥3 cm².

3) Why a two‑stage option is considered despite the extra complexity

Compared with single‑stage approaches, MACI/ACI demands more planning and resources (two operations and a lab‑manufactured implant). The trade‑off is that these procedures are designed specifically for situations where a small scaffold, membrane‑stabilised marrow repair, or an autograft “plug” becomes harder to justify—such as when the defect is simply too large, or when several areas need treatment at the same sitting. Technical and outcome reports also describe using MACI membranes to cover multiple defects in one knee after each lesion is debrided to stable margins.

A recurring caution in the surgical literature is that prior marrow‑stimulation procedures (for example microfracture) can alter the subchondral bone and, in certain cases, may make later cell‑based repair less predictable. This is one reason many specialist pathways treat the “sequence” of procedures as part of the decision, not just the label on the operation.

4) Edge cases: emerging single‑treatment ACI ideas, and very large defects

So‑called single‑treatment ACI concepts (sometimes grouped as “next‑generation” ACI) aim to keep some advantages of cell‑based repair while avoiding a separate harvest‑and‑reimplant pathway. These approaches are still evolving, and knee‑specific evidence is generally less mature than for conventional MACI.

At the far end of the spectrum—where the defect is very large, or involves substantial bone loss—some knee algorithms also discuss osteochondral allograft (a donor bone‑and‑cartilage graft) as an option in selected cases. As with MACI/ACI, the deciding factors are usually the lesion map (size, depth, and location) and whether the rest of the knee is suitable for joint preservation rather than replacement.

How does bow‑legged alignment point you toward HTO?

A familiar pattern is: bow‑legged (varus) alignment, pain mainly on the inside (medial) of the knee, and X‑rays showing medial joint‑space narrowing. That combination often points to a load problem—the inner compartment is being asked to carry more of the body’s weight on every step—rather than a single “pothole” cartilage defect that can be treated in isolation. In that setting, the key question becomes how to unload the medial compartment, not just how to fill a defect. [msk_kb:5adfff34-7528-4c80-93a0-47d18191673d]

High Tibial Osteotomy (HTO) addresses that overload by re‑aligning the leg. In simple terms, it is a controlled cut in the upper shin bone (proximal tibia) that is opened or closed to straighten the limb so the weight‑bearing line shifts away from the worn medial side towards the healthier outer compartment. The correction is held with metalwork (typically a plate and screws) while the bone heals, with the goal of improving pain and function while delaying knee replacement in suitable unicompartmental wear patterns. [msk_kb:5adfff34-7528-4c80-93a0-47d18191673d]

Evidence comparing unloading options suggests that, in younger surgical candidates, osteotomy tends to produce stronger short‑term symptom relief than bracing alone. A multicentre randomised trial in adults aged 18–65 years with symptomatic medial compartment osteoarthritis reported a much larger improvement in KOOS pain at 12 months after HTO than after a valgus unloader brace (about a 28‑point between‑group difference in favour of surgery). [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11747842%2F]

Longer‑term data are one reason HTO is often positioned as a joint‑preserving “strategy” for people aiming to stay active. In a 2024 systematic review of valgus‑producing HTO in radiographically advanced medial osteoarthritis (18 studies, 1296 knees), average survivorship without conversion to total knee replacement was about 75% at 10 years. A separate 20‑year series reported overall survivorship of 44%, rising to 62% at 20 years in a favourable subgroup (age <55 years and BMI <30). [ai4scholar:ed9e084059d401cc7c1641f6f3c5f8556e8e9d2e, ai4scholar:c0ece0c0b3bd0c4c2c7333038d8664a8d62f2f60]

In knees where there is both varus medial wear and a dominant focal defect, surgeons often link mechanics and biology in one plan: unload the compartment with HTO and address the worst local cartilage/bone damage with a focal technique in the same sitting (for example, an osteochondral autograft). One report of 66 knees treated with medial opening‑wedge HTO plus OATS followed patients for a mean of 9.5 years, with 96.7% survivorship without knee replacement and second‑look arthroscopy describing mostly hyaline‑like repair tissue. [ai4scholar:d2ac7e29054c07fc6c9f6b5ace9761a40d78d36c]

HTO is still a bone‑cutting operation, so the risk profile matters in decision‑making. A systematic review across 71 studies (7836 patients) reported intra‑operative complications of about 5.5% and post‑operative complications of about 6.9%, with relatively low rates of nonunion (~1.9%), loss of correction (~1.2%), and implant failure (~1.0%)—balanced against the more powerful and often more durable unloading effect compared with non‑operative measures in appropriately selected varus medial compartment disease. [ai4scholar:53ef88770aa8f15e4913dbc240c03d02bd34488d]

Unloader knee brace or HTO surgery – which first?

Choosing between an unloader brace and a high tibial osteotomy (HTO) usually comes down to two practical questions: whether symptoms can be brought under control without an operation in the next 6–12 months, and whether a stronger, longer-lasting unloading effect is needed to keep the knee functioning at work and on daily walks. (To avoid repeating earlier headline trial figures, the focus here is on what “brace success” and “brace failure” tend to look like in day-to-day life.)

What an unloader (offloader) knee brace actually does

An unloader brace is designed to “bias” the knee away from the worn compartment using a three-point leverage system (thigh and calf shells with a dynamic force strap), most often to reduce load on the medial (inner) side in a varus (bow‑legged) knee with medial compartment osteoarthritis. In cohort research and manufacturer summaries, this type of bracing has been associated with reduced pain, improved function, and reduced use of pain medication/anti‑inflammatories in unicompartmental knee OA. [trafilatura:https%3A%2F%2Fwww.ossur.com%2Fen-gb%2Fbracing-and-supports%2Funloader%2Funloader-braces]

What can realistically be expected from bracing (when it goes well)

Published trial evidence supports bracing as a meaningful, joint‑preserving option when paired with a structured programme. In a 120‑patient randomised trial in Kellgren–Lawrence grade II–III knee OA, a combined programme of static cycling + TENS + an unloader brace delivered the greatest improvements in pain and function outcomes and was associated with a lower 1‑year arthroplasty rate (6.7% vs 25% with standard care). That sort of result fits the common brace “win”: less pain on a 20‑minute dog walk, fewer flare‑ups on stairs, and less reliance on regular analgesia—without committing to surgery. [ai4scholar:c44e1507cbe4e15066f5187f8334319096335cf9]

What extra does HTO offer in the right candidate?

For surgically suitable adults (the RCT enrolled people aged 18–65 with symptomatic medial compartment OA), a valgus-producing HTO has been shown to deliver a much larger improvement in pain and function at 12 months than valgus unloader bracing. The practical implication is that, where the aim is a bigger step-change in symptoms and capacity (for example, coping with an 8‑hour shift involving standing, or returning to longer hill walks), osteotomy tends to be the more powerful unloading tool than bracing alone. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11747842%2F]

Longer-term follow-up studies and systematic reviews also position HTO as a joint-preserving strategy that can delay knee replacement for many patients over the course of years to a decade-plus, including some with more advanced medial disease. [ai4scholar:ed9e084059d401cc7c1641f6f3c5f8556e8e9d2e, ai4scholar:c0ece0c0b3bd0c4c2c7333038d8664a8d62f2f60]

Day-to-day trade-offs: brace vs osteotomy

A brace is non-surgical and reversible, which matters in 2026 real-world life where work, caring responsibilities, and other health issues can make an operation difficult to time. Common “brace limitations” include bulk under clothes, skin irritation, trouble with consistent wear in warm weather, and the simple reality that intermittent use often delivers intermittent benefit. [trafilatura:https%3A%2F%2Fwww.ossur.com%2Fen-gb%2Fbracing-and-supports%2Funloader%2Funloader-braces]

HTO is a one-off operation with hospital-based recovery and structured rehabilitation, and it brings surgical risks that bracing does not. A large systematic review (71 studies, 7,836 patients) reported complication rates in the single-digit percentages overall, with issues such as hinge fractures and (more rarely) nonunion, loss of correction, implant failure, or neurovascular injury—important context when weighing “more effect” against “more disruption”. [ai4scholar:53ef88770aa8f15e4913dbc240c03d02bd34488d]

A practical sequencing hinge (and where uncertainty sits)

A common pathway is to use bracing as a time-limited test of mechanical unloading: if consistent brace wear plus rehab restores the activities that matter (walking, stairs, standing tolerance) over a defined period such as 8–12 weeks, it may be reasonable to continue non-operative care. If the brace is poorly tolerated, only helps for a few hours, or function remains capped (for example, still unable to manage a regular commute or longer walks), the RCT evidence suggests HTO is more likely to produce a larger improvement when the knee is otherwise suitable for preservation. The exact “best” duration of a brace trial before moving to surgery remains an area where patient selection and timing are still being refined in research, but the day-to-day decision point is usually whether bracing delivers dependable, repeatable relief or merely occasional symptom dampening. [ai4scholar:c44e1507cbe4e15066f5187f8334319096335cf9, trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11747842%2F]

How we tailor joint‑preserving plans at Lincolnshire Knee

A joint‑preserving knee plan tends to be clearer when it is framed as a staged pathway rather than a menu of procedures: (1) symptom management (physiotherapy, activity modification, weight management and appropriate pain relief), (2) biologic / injection support where it fits the wider plan, (3) cartilage restoration or scaffold‑based repair when there is a suitable focal target, and (4) partial or total knee replacement when wear is too diffuse for preservation to be realistic. Knee cartilage algorithms repeatedly make the same separation: symptomatic focal full‑thickness defects (often post‑traumatic) are where restorative techniques fit best, while degenerative, multi‑area osteoarthritis is less likely to respond to isolated “cartilage fixes”. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

In practice, the “mapping” step matters as much as the treatment step. A consultant‑led work‑up typically combines a detailed history and examination with standing alignment X‑rays (to check varus/valgus load patterns) and a high‑quality MRI to define whether the problem is a single contained defect, broader cartilage wear, meniscal deficiency, or a mix. Where it changes decision‑making, more advanced MRI analysis (for example, cartilage/meniscus segmentation) and objective movement assessment can be used to link structure to loading mechanics, particularly in knees where symptoms and imaging do not match neatly.

From there, the decision logic usually runs along recognisable “if–then” lines, based on lesion pattern, alignment and size thresholds reported in knee cartilage literature:

• Focal, symptomatic defects in an otherwise well‑aligned knee: single‑stage options are often considered first for small‑to‑moderate lesions (for example OATS around the 2–4 cm² range in young, active patients) and matrix‑augmented approaches such as AMIC for selected full‑thickness defects; two‑stage cell therapies such as MACI are more often positioned for larger lesions (the SUMMIT data discussed outcomes in defects ≥3 cm²) or more complex patterns. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F, ai4scholar:5638c3e03734da5251541d55cbaea77a33907e31, msk_kb:ae70b3f2-44ee-4a0b-91cb-abccc715523d]
• Early arthritis with malalignment (for example varus medial overload): the “cartilage question” and the “mechanics question” are linked, so realignment with high tibial osteotomy (HTO) and/or a time‑limited trial of unloader bracing is usually part of the discussion, rather than treating the cartilage surface in isolation. [ai4scholar:ed9e084059d401cc7c1641f6f3c5f8556e8e9d2e, trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11747842%2F]
• Advanced, multi‑compartment wear: restorative procedures are less likely to change the overall trajectory, so it becomes more appropriate to talk about partial or total knee replacement options and timing, rather than layering multiple preservation procedures with uncertain durability. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4000472%2F]

Expectations also need to stay realistic. Even when imaging shows a good “target”, the aim is usually to reduce pain, improve function and delay knee replacement, not to “rewind the clock” to a pre‑injury knee. That is particularly important with newer or less well‑studied options: for example, published knee data on ChondroFiller are still largely limited to small early series (such as a 17‑patient report with 12‑month follow‑up), and some scaffold‑plus‑biologics approaches in very advanced osteoarthritis have only short follow‑up (for example 2 months in a small grade‑IV OA study). By contrast, established joint‑preserving strategies such as HTO and established restorative options such as OATS and MACI generally have a deeper mid‑ to long‑term evidence base in the knee. [trafilatura:https%3A%2F%2Fwww.journal-imab-bg.org%2Fissues-2024%2Fissue4%2Fvol30issue4p5936-5941.html, trafilatura:https%3A%2F%2Fwww.gavinpublishers.com%2Farticle%2Fview%2Fjoint-preservation-in-patients-with-grade-iv-osteoarthritis-of-the-knee-use-of-an-acellular-collagen-scaffold-chondrofiller-liquid-and-blood-derived-stem-cell-rich-graft-a-prospective-controlled-trial, ai4scholar:c0ece0c0b3bd0c4c2c7333038d8664a8d62f2f60, ai4scholar:5638c3e03734da5251541d55cbaea77a33907e31, msk_kb:ae70b3f2-44ee-4a0b-91cb-abccc715523d]

This conclusion deliberately keeps clinic‑specific detail to a single closing line, and centres on the staging framework above rather than a brochure‑style recap. For a personalised knee assessment within that framework, Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral; appointments can be booked at lincolnshireknee.co.uk.

1. [1] Evaluating single-stage cartilage treatments in the knee: A systematic review and meta-analysis of osteochondral autograft transfer surgery (OATS) and minced cartilage repair (MCR) techniques. (2026). https://doi.org/10.1016/j.jor.2025.12.052 https://doi.org/10.1016/j.jor.2025.12.052